CIK: 0001493215 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 15, 2017
Total Value ($000): $265,662 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Avexis Inc | 849,043 | $40,525 | 15.3% | $33.55 | — | COM | 05366U100 |
| BMY | Bristol Myers Squibb Co | 565,888 | $33,070 | 12.4% | $42.72 | -7.5% | COM | 110122108 |
| ALNY | Alnylam Pharmaceuticals Inc | 789,208 | $29,548 | 11.1% | $86.12 | -51.4% | COM | 02043Q107 |
| BCRX | Biocryst Pharmaceuticals | 4,078,895 | $25,819 | 9.7% | $7.25 | -28.2% | COM | 09058V103 |
| — | La Jolla Pharmaceutical Co | 1,086,037 | $19,038 | 7.2% | $25.02 | — | COM PAR $.0001 2 | 503459604 |
| — | Agenus Inc | 4,210,264 | $17,346 | 6.5% | $7.60 | — | COM NEW | 00847G705 |
| — | Medicines Co | 374,263 | $12,702 | 4.8% | $35.19 | — | COM | 584688105 |
| PTCT | PTC Therapeutics Inc | 997,166 | $10,879 | 4.1% | $10.49 | 0.0% | COM | 69366J200 |
| INCY | Incyte Corp | 86,757 | $8,699 | 3.3% | $74.63 | +30.7% | COM | 45337C102 |
| — | Oxford Immunotec Global PLC | 543,287 | $8,122 | 3.1% | $13.91 | — | ORD SHS | G6855A103 |
| — | United States Oil Fund LP | 675,000 | $7,911 | 3.0% | $11.72 | — | UNITS | 91232N108 |
| — | bluebird bio Inc | 122,576 | $7,563 | 2.8% | $48.74 | — | COM | 09609G100 |
| — | Dicerna Pharmaceuticals Inc | 2,043,216 | $5,884 | 2.2% | $13.12 | — | COM | 253031108 |
| MASI | Masimo Corp | 80,900 | $5,453 | 2.1% | $54.87 | +12.0% | COM | 574795100 |
| — | Atara Biotherapeutics Inc | 372,624 | $5,291 | 2.0% | $14.20 | — | COM | 046513107 |
| — | Corium Intl Inc | 1,101,045 | $4,470 | 1.7% | $9.09 | — | COM | 21887L107 |
| RGNX | Regenxbio Inc | 239,789 | $4,448 | 1.7% | $24.07 | -20.6% | COM | 75901B107 |
| — | Viveve Med Inc | 839,666 | $4,324 | 1.6% | $4.19 | — | COM NEW | 92852W204 |
| TCMD | Tactile Sys Technology Inc | 248,762 | $4,082 | 1.5% | $15.52 | +11.7% | COM | 87357P100 |
| — | Invuity Inc | 454,900 | $2,616 | 1.0% | $12.22 | — | COM NEW | 46187J205 |
| OMER | Omeros Corp | 259,039 | $2,570 | 1.0% | $14.29 | -28.6% | COM | 682143102 |
| — | Achillion Pharmaceuticals In | 286,285 | $1,182 | 0.4% | $10.21 | — | COM | 00448Q201 |
| — | Celldex Therapeutics Inc New | 239,662 | $848 | 0.3% | $12.18 | — | COM | 15117B103 |
| SRTS | Sensus Heatlhcare Inc | 122,803 | $645 | 0.2% | $6.26 | -6.2% | COM | 81728J109 |
| — | Mirati Therapeutics Inc | 129,697 | $616 | 0.2% | $33.11 | — | COM | 60468T105 |
| — | Biopharmx Corp | 1,273,128 | $476 | 0.2% | $1.20 | — | COM | 09072X101 |
| — | Global Blood Therapeutics In | 25,963 | $375 | 0.1% | $35.72 | — | COM | 37890U108 |
| NTRA | Natera Inc | 31,693 | $371 | 0.1% | $16.90 | -34.9% | COM | 632307104 |
| — | Audentes Therapeutics Inc | 20,000 | $365 | 0.1% | $17.80 | — | COM | 05070R104 |
| — | Mannkind Corp | 438,500 | $279 | 0.1% | — | — | Put | 56400P201 |
| — | Sensus Heatlhcare Inc | 155,000 | $78 | 0.0% | $0.50 | — | WARRANTS EXP 12/31/2019 | 81728J117 |
| — | Nivalis Therapeutics Inc | 30,000 | $67 | 0.0% | $15.17 | — | COM | 65481J109 |